Edition:
United Kingdom

People: Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

22.65USD
6:42pm BST
Change (% chg)

$-0.05 (-0.22%)
Prev Close
$22.70
Open
$23.06
Day's High
$23.22
Day's Low
$22.59
Volume
83,233
Avg. Vol
261,092
52-wk High
$41.40
52-wk Low
$17.90

Albright, Charles 

Dr. Charles Albright Ph.D., is a Chief Scientific Officer of the EDITAS MEDICINE, INC. since August 2016. Prior to joining Editas, Albright served in a variety of roles at Bristol-Myers Squibb Company, a biopharmaceutical company, from January 2004 to August 2016, serving most recently as the Vice President, Genetically Defined Diseases and Genomics. Dr. Albright received his B.S. in chemical engineering and a Ph.D. in biology from the Massachusetts Institute of Technology.

Basic Compensation

Total Annual Compensation, USD 492,773
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 773,862
Fiscal Year Total, USD 1,266,640

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Mullen

--

Cynthia Collins

--

Charles Albright

1,266,640

Gerald Cox

2,467,450

Katrine Bosley

6,091,500

Andrew Hirsch

246,416
As Of  31 Dec 2017